| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Randolph C Steer last filed a Form 4 in October 2023, as Director at TECH.
Randolph C Steer has 18 Form 4 filings on record from January 2015 to October 2023, across 3 companies: Director at Bio-Techne (TECH), 2015–2023; Director at Immunic (IMUX), 2015–2017; Consultant at Capstone (CAPS), 2015.
The 38 reported transactions were 15 option or other derivative awards, 10 open-market sales, 9 stock awards and 4 option exercises.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $7.2M.
The largest open-market sale was 8,000 shares of TECH at an average $509.98 on September 7, 2021, about $4.1M. Twelve months later TECH was down 35%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.